Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 18,921 shares at $49.57 ($938K) on 2026-08-25, disclosed to the SEC on 2026-08-26.
Scheduled sale ($938k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RAPP | SELL | 2026-08-12 | $2.4M | — | Filing → |
| RAPP | SELL | 2026-07-29 | $93K | — | Filing → |
| RAPP | SELL | 2026-07-15 | $328K | — | Filing → |